“…Notable examples encompass APC, AKT1 , and CDH1 in Gastric Cancer, KRT18, CYP4A11, SLC4A3, SLC26A5, KCNS1, ABCD1, YTHDC2, PINX1, TNRC6A, TACO1, LAMA1, ACP7 and ACP7 in Type 2 Diabetes, as well as MT-ND2, MT-ND6, NOTCH1 and FLT3 in Pediatric Leukaemia patients from Mizoram. 20 , 21 , 22 , 23 , 24 , 25 These genetic deviations may owe their existence to the distinctive attributes of the population, potentially serving as pivotal research entry points for exploring potential predisposition mechanisms. As an illustration, the DPYD gene encodes DPD, a determinant governing the bioavailability of 5-Fluorouracil, thus determining treatment efficacy and toxicity for solid tumour patients.…”